title: A serum amyloid A and LDL complex as a new prognostic marker in stable coronary artery disease.
abstract: BACKGROUND
  Although some reports have indicated that acute phase proteins such as C-reactive protein (CRP) and serum amyloid A (SAA) can predict the prognosis in patients with acute coronary syndrome, the value of these markers in patients with stable coronary artery disease (CAD) still remains obscure. Therefore, our aim was to determine the prognostic value of inflammatory markers in patients with stable coronary artery disease.
  
  
  RESULTS
  We conducted a prospective cohort study in 140 consecutive patients with stable coronary artery disease who had at least one coronary stenosis more than 50% in diameter seen on diagnostic coronary angiography (CAG). We determined serum levels of the SAA/LDL complex as a new marker in addition to CRP and SAA. Serum levels of the SAA/LDL complex were measured by a sandwich enzyme-linked immunosorbent assay (ELISA). End-points were defined as cardiac death, myocardial infarction, cerebral infarction, and coronary revascularization. End-point events occurred in 21 patients (2 death from myocardial infarction, 2 cerebral infarction, and 17 revascularization). Age (year) (OR = 1.14, CI: 1.05-1.25), diabetes mellitus (OR = 3.50, CI: 1.08-11.40), triglyceride (10mg/dl) (OR = 1.12, CI: 1.01-1.23) and SAA/LDL complex (10 microg/ml) (OR = 2.32, CI: 1.05-4.70) were independently related to the events. A reconstitution experiment suggested that the SAA/LDL complex is derived by oxidative interaction between SAA and lipoproteins.
  
  
  CONCLUSIONS
  The SAA/LDL complex reflects intravascular inflammation directly and can be a new marker more sensitive than CRP or SAA for prediction of prognosis in patients with stable coronary artery disease.
authors.affiliation: The Cardiovascular Institute, Roppongi 7-3-10 Minato-ku, Tokyo 106-0032, Japan. ij3k-ogsw@asahi-net.or.jp
authors.forename: Ken
authors.initials: K
authors.lastname: Ogasawara
authors.forename: Shinichi
authors.initials: S
authors.lastname: Mashiba
authors.forename: Youichiro
authors.initials: Y
authors.lastname: Wada
authors.forename: Makoto
authors.initials: M
authors.lastname: Sahara
authors.forename: Kazuo
authors.initials: K
authors.lastname: Uchida
authors.forename: Tadanori
authors.initials: T
authors.lastname: Aizawa
authors.forename: Tatsuhiko
authors.initials: T
authors.lastname: Kodama
mesh_terms: D000368:Aged; D015415:Biomarkers / Q000097:blood; D015331:Cohort Studies; D016001:Confidence Intervals; D017023:Coronary Angiography; D003324:Coronary Artery Disease / Q000097:blood* / Q000000981:diagnostic imaging; D005260:Female; D006801:Humans; D008077:Lipoproteins, LDL / Q000097:blood*; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D011336:Probability; D011379:Prognosis; D011446:Prospective Studies; D018570:Risk Assessment; D000685:Serum Amyloid A Protein / Q000032:analysis*; D012720:Severity of Illness Index
chemical_list: D015415:Biomarkers; D008077:Lipoproteins, LDL; D000685:Serum Amyloid A Protein